[Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment]

Ugeskr Laeger. 2005 Feb 21;167(8):898-900.
[Article in Danish]
No abstract available

MeSH terms

  • Bone Density / drug effects
  • Calcitonin / administration & dosage
  • Calcium / administration & dosage
  • Calcium / metabolism
  • Diphosphonates / administration & dosage
  • Estrogen Receptor Modulators / administration & dosage
  • Estrogens / administration & dosage
  • Female
  • Fractures, Spontaneous / prevention & control
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / adverse effects*
  • Humans
  • Incidence
  • Male
  • Osteoblasts / drug effects
  • Osteoporosis / chemically induced*
  • Osteoporosis / epidemiology
  • Osteoporosis / prevention & control
  • Osteoporosis, Postmenopausal / chemically induced
  • Osteoporosis, Postmenopausal / epidemiology
  • Osteoporosis, Postmenopausal / prevention & control
  • Risk Factors
  • Teriparatide / administration & dosage
  • Vitamin D / administration & dosage

Substances

  • Diphosphonates
  • Estrogen Receptor Modulators
  • Estrogens
  • Glucocorticoids
  • Teriparatide
  • Vitamin D
  • Calcitonin
  • Calcium